Alternatively, PHD-3 may represent another promising candidate for manipulation in the setting of wound healing and ischemia: Loinard et al. found treatment with shPHD-3 to be slightly superior to shPHD-2 in promoting ischemic limb revascularization [28]. Here, EGLN3 is linked to ischemia.